Reading Time : 2 minutesDatabricks’ AiChemy deploys multi-agent AI to fuse public and private data for faster drug leads, from target ID to compound matching. Fully traceable and customizable, it eyes slashing early development costs. Is this pharma’s AI turning point?
Reading Time : 2 minutes Trump’s new 25% tariffs on pharmaceuticals aim to boost U.S. manufacturing. The move could reshape global drug supply chains and spark retaliation. Major exporters like Ireland, China, and Germany may face steep losses. Consumers in the U.S. could see rising prices.
Reading Time : 2 minutes AI is revolutionizing drug discovery by predicting how new compounds interact with biological targets, potentially reducing development time and costs. However, challenges like regulatory adaptation, data privacy, and real-world efficacy must be addressed for widespread success.
